FDA Bill Passes; Congress Adds $225 Million To Industry User Fee Burden
Executive Summary
Final FDA reform legislation that cleared Congress adds an additional $225 million to industry's user fee tab over five years, but limits penalties that FDA can assess to enforce its new authorities to mandate labeling changes and postmarket studies
You may also be interested in...
FDA Working To Fill Advisory Panel Vacancies While Tightening Conflict-Of-Interest Rules
FDA is working on an initiative to fill many of the current vacancies on its advisory committees, but it is not backing down from a strict conflict-of-interest policy that many see as contributing to the advisory panel vacancies
FDA Working To Fill Advisory Panel Vacancies While Tightening Conflict-Of-Interest Rules
FDA is working on an initiative to fill many of the current vacancies on its advisory committees, but it is not backing down from a strict conflict-of-interest policy that many see as contributing to the advisory panel vacancies
FDA Working To Fill Advisory Panel Vacancies While Tightening Conflict-Of-Interest Rules
FDA's revised draft guidance adds requirement for public disclosure of the company or institution that is the source of a conflict.